Ad is loading...
AFCGX
Price
$17.06
Change
-$0.30 (-1.73%)
Updated
Nov 15 closing price
RERAX
Price
$53.01
Change
-$0.52 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

AFCGX vs RERAX

Header iconAFCGX vs RERAX Comparison
Open Charts AFCGX vs RERAXBanner chart's image
American Century Focused Intl Gr G
Price$17.06
Change-$0.30 (-1.73%)
VolumeN/A
CapitalizationN/A
American Funds Europacific Growth R1
Price$53.01
Change-$0.52 (-0.97%)
VolumeN/A
CapitalizationN/A
AFCGX vs RERAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AFCGX vs. RERAX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AFCGX is a StrongSell and RERAX is a Buy.

FUNDAMENTALS
Fundamentals
RERAX has more cash in the bank: 129B vs. AFCGX (105M). AFCGX pays higher dividends than RERAX: AFCGX (1.28) vs RERAX (0.91). AFCGX was incepted earlier than RERAX: AFCGX (6 years) vs RERAX (22 years). AFCGX is a more actively managed with annual turnover of: 61.00 vs. RERAX (34.00). AFCGX has a lower initial minimum investment than RERAX: AFCGX (0) vs RERAX (250). AFCGX annual gain was more profitable for investors over the last year : 12.71 vs. RERAX (7.63). AFCGX return over 5 years is better than : 23.44 vs. RERAX (3.85).
AFCGXRERAXAFCGX / RERAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years22 years-
Gain YTD4.9853.052163%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets105M129B0%
Annual Yield % from dividends1.280.91140%
Returns for 1 year12.717.63167%
Returns for 3 years-18.94-19.4597%
Returns for 5 years23.443.85608%
Returns for 10 yearsN/A15.89-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APP291.096.60
+2.32%
Applovin Corp
BBDC9.950.06
+0.61%
Barings BDC
SIF3.60N/A
N/A
SIFCO Industries
CNS100.47-0.25
-0.25%
Cohen & Steers
FATE2.02-0.06
-2.88%
Fate Therapeutics